FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

K C Pharmaceuticals Eye Drops Industrial Strength Recall

Eye Drops Industrial Strength (Polyethylene glycol 400 1%, Tetrahydrozoline HCl 0

K C Pharmaceuticals Inc · Pomona, CA

Risk level
Class III
Reported by FDA
Dec 31, 2014
Recall ID
D-0322-2015
Check your lot numberHow we source this data

Summary

K C Pharmaceuticals recalled Eye Drops Industrial Strength starting Dec 4, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0322-2015 on Dec 31, 2014. Reason: CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy. Status: Terminated.

Why it was recalled

CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.

Product description

Eye Drops Industrial Strength (Polyethylene glycol 400 1%, Tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) Bottles, Over the Counter. Labeled: a) Manufactured for: Petragon, Inc., Edwardsville, KS 66111; b) SWIFT, Distributed by Swift First Aid, Inc., Valencia, Calif. 91355, UPC: 6 69635 24082 5; c) Xpect First aid, Manufactured for Cintas First Aid & Safety, Mason, OH 45040; d) ZEE, Distributed by ZEE MEDICAL, INC., Irvine, CA 92606, UPC: 6 90689 00609 9.

Lot numbers, UPCs & expiration codes

Lot #: 3A450, Expiry: 01/06.

Where it was sold

U.S. Nationwide and Canada (Ontario).

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0322-2015
Classification
Class III
Status
Terminated
Recall initiated
Dec 4, 2014
FDA report date
Dec 31, 2014
Quantity
71904 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
K C Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0322-2015, exactly as published.

Show all FDA fields
City
Pomona
State
CA
Status
Terminated
Country
United States
Event ID
69945
Address
3201 Producer Way
Code information
Lot #: 3A450, Expiry: 01/06.
Postal code
91768-3916
Report date
Dec 31, 2014
Product type
Drugs
Recall number
D-0322-2015
Classification
Class III
Recalling firm
K C Pharmaceuticals Inc
Product quantity
71904 Bottles
Termination date
Oct 26, 2015
Reason for recall
CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Eye Drops Industrial Strength (Polyethylene glycol 400 1%, Tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) Bottles, Over the Counter. Labeled: a) Manufactured for: Petragon, Inc., Edwardsville, KS 66111; b) SWIFT, Distributed by Swift First Aid, Inc., Valencia, Calif. 91355, UPC: 6 69635 24082 5; c) Xpect First aid, Manufactured for Cintas First Aid & Safety, Mason, OH 45040; d) ZEE, Distributed by ZEE MEDICAL, INC., Irvine, CA 92606, UPC: 6 90689 00609 9.
Distribution pattern
U.S. Nationwide and Canada (Ontario).
Recall initiation date
Dec 4, 2014
Initial firm notification
Letter
Center classification date
Dec 23, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0322-2015, published Dec 31, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls